FDA approves generic of AstraZeneca asthma drug (San Francisco Chronicle)
AstraZeneca PLC said Wednesday it is launching a generic version of its own child asthma medication Pulmicort Respules after U.S. regulators paved the way for its rival Teva Pharmaceutical Industries Ltd. to do the same. The London-based drug maker also filed...
Home > About This Post
This entry was posted by admin on Wednesday, November 19th, 2008, at 10:45 am, and was filed in asthma.
Subscribe to the
RSS 2.0 feed for all comments to this post.
Post a Comment